Cue Health Inc.
HLTHDelisted Jun 28, 2024- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001628945
Cue Health Inc. was delisted on Jun 28, 2024; its insiders filed their last Form 4 on Aug 27, 2024; 58 institutions reported holding it in 13F filings for Q1 2024, worth $13.8M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Cue Health Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 80 | 73 | −7 |
| Shares | 82.5M | 80.0M | −2.46M (−3.0%) |
| Value | $30.5M | $35.4M | +$4.90M (+16.1%) |
New holders (7)
Institutions that held Cue Health Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tarsadia Capital, LLC | 10,684,791 | $4.73M | 24.61% |
| National Asset Management, Inc. | 260,000 | $115.0K | 0.00% |
| Two Sigma Advisers, LP | 227,900 | $100.8K | 0.00% |
| Janney Montgomery Scott LLC | 17,436 | $8.00K | 0.00% |
| ProShare Advisors LLC | 10,036 | $4.44K | 0.00% |
| Citadel Advisors LLC | 4,472 | $1.98K | 0.00% |
| The PNC Financial Services Group, Inc. | 800 | $354 | 0.00% |
Sold out (14)
Institutions that held Cue Health Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Deutsche Bank AG | 787,429 | $290.6K |
| Y-Intercept (Hong Kong) Ltd | 332,668 | $122.8K |
| Old Mission Capital LLC | 257,136 | $94.9K |
| Charles Schwab Investment Management Inc | 41,972 | $15.5K |
| FFT Wealth Management LLC | 41,349 | $15.3K |
| Virtu Financial LLC | 35,164 | $13.0K |
| HRT Financial LP | 31,199 | $11.0K |
| Point72 Middle East FZE | 19,305 | $7.12K |
| Cubist Systematic Strategies, LLC | 17,172 | $6.34K |
| Point72 Asset Management, L.P. | 5,195 | $1.92K |
| New York State Common Retirement Fund | 924 | $341 |
| FMR LLC | 511 | $189 |
| Royal Bank of Canada | 407 | $0 |
| Valley National Advisers Inc | 313 | – |